People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications
They address the underlying biology of hunger, satiety, and metabolism rather than simply trying to override it
Liraglutide is typically started at a low dose and increased gradually to improve tolerance
We check your metabolic hormones, thyroid, blood sugar, and more to understand your unique metabolic barriers
Frequently Asked Questions Can I take retatrutide without being enrolled in a clinical trial
Its best to talk with your healthcare provider about the risks and benefits for you